We are conducting a research study for adults who smoke cigarettes daily. This study will be evaluating the effectiveness of investigational Cytisinicline for smoking cessation.
Cytisine is a plant-based alkaloid that is believed to potentially reduce the severity of nicotine withdrawal symptoms by targeting nicotinic acetylcholine receptors (nAChRs) in the brain. “Cytisinicline” is the generic name for cytisine.
You may be eligible if you:
- Are 18 and older
- Smoke an average of at least 10 cigarettes per day
- Intend to quit smoking
- Have tried and failed to quit smoking before
There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related investigational medication (or placebo) and medical exams at no cost, as well as reimbursement for time and travel. No health insurance is required to participate.
For more information call
Or sign up, our office will call you!
- Jacksonville (All Sites)